Dario Romagnoli
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing.
Journal: Genome medicine
Published: August 01, 2025
Molecular and Clinical Analyses of Gene Fusions Identify Therapeutic Targets in Paired Primary and Metastatic Breast Cancer from the AURORA Program (BIG 14-01).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 21, 2025
Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines.
Journal: NPJ breast cancer
Published: February 27, 2025
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer.
Journal: NPJ breast cancer
Published: September 19, 2024
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.
Journal: JCO precision oncology
Published: March 01, 2024
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples.
Journal: Briefings in bioinformatics
Published: November 16, 2022
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
Journal: Cancer research
Published: September 26, 2022
Charting differentially methylated regions in cancer with Rocker-meth.
Journal: Communications biology
Published: March 27, 2021
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
Journal: Cancer discovery
Published: November 11, 2020
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology.
Journal: Biomolecules
Published: October 27, 2020
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
Journal: Breast cancer research : BCR
Published: October 16, 2020
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 08, 2019
Last Updated: 09/26/2026